Reduced Occurrence of Tumor Flare with Flavopiridol Followed by Combined Flavopiridol and Lenalidomidein Patients with Relapsed Chronic Lymphocytic Leukemia (CLL)

Flavopiridol and lenalidomide have activity in refractory CLL without immunosuppression or opportunistic infections seen with other therapies. We hypothesized that flavopiridol treatment could adequately de-bulk disease prior to lenalidomide therapy, decreasing the incidence of tumor flare with high...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Maddocks, Kami, Wei, Lai, Rozewski, Darlene, Jiang, Yao, Zhao, Yuan, Adusumilli, Mikhil, Pierceall, William E., Doykin, Camille, Cardone, Michael H., Jones, Jeffrey A., Flynn, Joseph, Andritsos, Leslie A., Grever, Michael R., Byrd, John C., Johnson, Amy J., Phelps, Mitch A., Blum, Kristie A
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552311/
https://ncbi.nlm.nih.gov/pubmed/25639448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23946
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados